BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 35860906)

  • 1. Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes.
    Liu D; Zhao L; Jiang Y; Li L; Guo M; Mu Y; Zhu H
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2456-2472. PubMed ID: 35860906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profiling of patients with different idiopathic inflammatory myopathy subtypes reveals potential biomarkers in plasma.
    Zhao Q; Hu Q; Meng S; Zhang Q; Wang T; Liu C; Liu D; Jiang Z; Hong X
    Clin Exp Med; 2023 Nov; 23(7):3417-3429. PubMed ID: 37103652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot.
    Bories E; Fortenfant F; Pugnet G; Renaudineau Y; Bost C
    Semin Arthritis Rheum; 2022 Aug; 55():151998. PubMed ID: 35427882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
    Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
    J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
    Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
    Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolomic analysis reveals disorder of steroid hormone biosynthesis in patients with idiopathic inflammatory myopathy.
    Huo T; Yuan X; Han J; Shi J; Xiong Y; Tian F; Xu Z; Cai M; Xu Y; Chen H; Zeng X; He W; Wang Q; Zhang J
    Front Immunol; 2023; 14():1188257. PubMed ID: 37377960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
    Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
    Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
    Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies.
    Lan JL; Chang SH; Tsay GJ; Chen DY; Chao YH; Li JP
    BMC Immunol; 2023 Sep; 24(1):33. PubMed ID: 37752437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
    Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
    Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.
    Piette Y; De Sloovere M; Vandendriessche S; Dehoorne J; De Bleecker JL; Van Praet L; Vander Mijnsbrugge AS; De Schepper S; Jacques P; De Keyser F; Smith V; Bonroy C
    Clin Exp Rheumatol; 2020; 38(2):212-219. PubMed ID: 31287411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of idiopathic inflammatory myopathies: pathology perspectives.
    Tanboon J; Nishino I
    Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience.
    Gudipati A; Rifat S; Uppin M; Jabeen A; Mathukumalli NL; Yareeda S; Kayidhi S; Pyal A; Dhamne M; Reddy YM
    Ann Indian Acad Neurol; 2023; 26(4):408-418. PubMed ID: 37970294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis.
    Zhang P; Li M; Zhang Y; Lian C; Sun J; He Y; Hu W; Wang L; Li T; Liu S; Zhang Y
    Clin Rheumatol; 2023 Aug; 42(8):2145-2154. PubMed ID: 37160775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
    Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
    Front Immunol; 2022; 13():879266. PubMed ID: 35603153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.